UFP Technologies Inc
NASDAQ:UFPT

Watchlist Manager
UFP Technologies Inc Logo
UFP Technologies Inc
NASDAQ:UFPT
Watchlist
Price: 197.38 USD -1.84%
Market Cap: $1.5B

EV/EBITDA

14.5
Current
27%
Cheaper
vs 3-y average of 19.9

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
14.5
=
Enterprise Value
$1.6B
/
EBITDA
$111.9m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
14.5
=
Enterprise Value
$1.6B
/
EBITDA
$111.9m

Valuation Scenarios

UFP Technologies Inc is trading below its 3-year average

If EV/EBITDA returns to its 3-Year Average (19.9), the stock would be worth $270.79 (37% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-11%
Maximum Upside
+37%
Average Upside
14%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 14.5 $197.38
0%
3-Year Average 19.9 $270.79
+37%
5-Year Average 19.1 $258.93
+31%
Industry Average 12.9 $175.06
-11%
Country Average 14.4 $195.03
-1%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
$1.6B
/
Jan 2026
$111.9m
=
14.5
Current
$1.6B
/
Dec 2026
$135.3m
=
11.7
Forward
$1.6B
/
Dec 2027
$146.6m
=
10.8
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
US
UFP Technologies Inc
NASDAQ:UFPT
1.6B USD 14.5 22.3
US
Medline Inc
NASDAQ:MDLN
63.4B USD 0 0
JP
Hoya Corp
TSE:7741
9.8T JPY 28.4 39.1
CH
Alcon AG
SIX:ALC
30.5B CHF 14.9 38.9
DK
Coloplast A/S
CSE:COLO B
98.2B DKK 12.9 24.5
US
Align Technology Inc
NASDAQ:ALGN
13.7B USD 14.9 34.2
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 11.9 34.2
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 17 -15.8
KR
HLB Inc
KOSDAQ:028300
8.4T KRW -84.9 -38
JP
Asahi Intecc Co Ltd
TSE:7747
895.2B JPY 23.9 50.6
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD 14.7 22.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
UFP Technologies Inc
NASDAQ:UFPT
Average EV/EBITDA: 17
14.5
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
JP
Hoya Corp
TSE:7741
28.4
13%
2.2
CH
Alcon AG
SIX:ALC
14.9
9%
1.7
DK
Coloplast A/S
CSE:COLO B
12.9
6%
2.2
US
Align Technology Inc
NASDAQ:ALGN
14.9
14%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
11.9
11%
1.1
CA
Bausch + Lomb Corp
NYSE:BLCO
17
29%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -84.9 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
23.9
13%
1.8
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.7
23%
0.6
P/E Multiple
Earnings Growth PEG
US
UFP Technologies Inc
NASDAQ:UFPT
Average P/E: 33.3
22.3
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
39.1
15%
2.6
CH
Alcon AG
SIX:ALC
38.9
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.5
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
34.2
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
34.2
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.8 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -38 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.6
40%
1.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
22.9
30%
0.8

Market Distribution

In line with most companies in the United States of America
Percentile
51th
Based on 9 875 companies
51th percentile
14.5
Low
0 — 10
Typical Range
10 — 21.5
High
21.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 10
Median 14.4
70th Percentile 21.5
Max 1 767 274.1

UFP Technologies Inc
Glance View

Amidst the evolving landscape of engineered materials and packaging solutions, UFP Technologies Inc. has emerged as a significant player, crafting its narrative through innovation and strategic positioning. Founded in 1963, this Massachusetts-based company has carved a niche for itself in the design and production of custom-engineered components, products, and specialty packaging for a vast array of industries. The medical sector, in particular, serves as a cornerstone of UFP's business model, offering intricate molded foam, thermoformed plastics, and molded fiber products designed to meet stringent regulatory standards. By embracing sophisticated design and manufacturing processes, UFP Technologies ensures that it delivers highly customized solutions tailored to the unique needs of each client, ranging from aerospace to automotive and electronics sectors. The financial engine driving UFP Technologies is its adeptness at understanding and anticipating the shifting demands of its diverse clientele, which allows for crafting optimized, cost-effective solutions. By not only selling products but also partnering with clients in the ideation and development phases, the company generates recurring revenues and fortifies long-term relationships with industry leaders. This client-centric approach, combined with an emphasis on innovation, underscores UFP's revenue streams, as they continually invest in research and development to stay ahead in the competitive market. The company’s strategic acquisitions further bolster its capacity and capabilities, enabling UFP Technologies to broaden its product offerings and reach new markets, thereby solidifying its position as a leader in custom-engineered solutions.

UFPT Intrinsic Value
203.4 USD
Undervaluation 3%
Intrinsic Value
Price $197.38
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett